Please provide your email address to receive an email when new articles are posted on . Age, nulliparity, polyps and shorter sampling intervals may predict endometrial hyperplasia and cancer. Risk ...

Please provide your email address to receive an email when new articles are posted on . Conjugated estrogen/bazedoxifene users had higher endometrial cancer and endometrial hyperplasia rates vs.

Malignant diseases are the second leading cause of death in women. [1] With an incidence of 24 in 100,000, endometrial cancer is the fourth most common cancer in women. [2] When diagnosed at an early ...

WHIPPANY, N.J.--(BUSINESS WIRE)-- Bayer announced today the start of its Phase III study SUNFLOWER, an investigational study evaluating the efficacy and safety of 52mg levonorgestrel-releasing ...

Tamoxifen treatment for premenopausal women with breast cancer is independently associated with an increased risk of endometrial cancer and other uterine diseases, according to findings from a large ...

A sequential doublet chemotherapy regimen in patients (pts) with advanced endometrial adenocarcinoma (EC) and gynecological mixed müllerian tumors (MMT). Maintaining activity with tolerability? No ...

Reproductive and Sexual Function After Platinum-Based Chemotherapy in Long-Term Ovarian Germ Cell Tumor Survivors: A Gynecologic Oncology Group Study This multicenter prospective study was carried out ...

Uterine cancer is the fourth most common cancer among women and the most common cancer of a woman's reproductive system. There are two major types of uterine cancer: Adenocarcinoma of the endometrium: ...